精品国产乱码一区,欧美自拍网站一二,亚洲AV熟女传媒一区二区三区,亚洲在线麻豆

咨詢熱線

15000266580

當(dāng)前位置:首頁 >產(chǎn)品中心>細(xì)胞庫>人正常細(xì)胞>CLHKGR02美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

簡(jiǎn)要描述:美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))
美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株
美國(guó)PrimCells誘導(dǎo)性穩(wěn)定細(xì)胞株: PrimCells建立的*的誘導(dǎo)性細(xì)胞高效開發(fā)系統(tǒng),能在極短時(shí)間內(nèi)篩選出低泄漏,高誘導(dǎo)性的穩(wěn)定細(xì)胞株,成功開發(fā)出一系列核受體誘導(dǎo)表達(dá)的穩(wěn)定細(xì)胞

  • 產(chǎn)品型號(hào):CLHKGR02
  • 廠商性質(zhì):生產(chǎn)廠家
  • 更新時(shí)間:2025-04-27
  • 訪  問  量:2128

產(chǎn)品分類

Product Category

詳細(xì)介紹

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))

美國(guó)PrimCells誘導(dǎo)性穩(wěn)定細(xì)胞株: PrimCells建立的*的誘導(dǎo)性細(xì)胞高效開發(fā)系統(tǒng),能在極短時(shí)間內(nèi)篩選出低泄漏,高誘導(dǎo)性的穩(wěn)定細(xì)胞株,成功開發(fā)出一系列核受體誘導(dǎo)表達(dá)的穩(wěn)定細(xì)胞株產(chǎn)品,為多家制藥公司研發(fā)部門和科研院所提供產(chǎn)品與服務(wù),廣受用戶好評(píng)。針對(duì)客戶的特定需求,PrimCells亦提供量身定制服務(wù),通過密切的客戶交流和高效的篩選體系,嚴(yán)格保證客戶在3-4周內(nèi)即獲得高質(zhì)量的誘導(dǎo)性穩(wěn)定細(xì)胞株,具有市場(chǎng)其他供應(yīng)商*的時(shí)效性。

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))


Introduction:

Nuclear hormone receptors (NHRs) are a superfamily of transcription factors that function as powerful metabolic regulators to control a variety of systemic processes in physiology. They also play key roles in the pathophysiology of many major disease states, such as diabetes, obesity, inflammation, atherosclerosis and heart failure. To date, this superfamily has provided a rich source of drug design targets and it is continuing to be one of the hottest areas for pharmaceutical research.

PrimCells now provides a comprehensive set of NHR expressing cell lines to the research community. These high-quality, Flag and/or HA-tagged NHR-expressing cell lines aim to facilitate further biochemical and molecular studies of their functions and hence encourage new strategies for drug design.

Glucocorticoids (GCs) are steroid hormones that allow us to cope with environmental and physiological stresses. Although GCs are widely used as anti-inflammatory agents in several clinical areas, long-term use of those steroids causes problems instead. Full achievement of the clinical potential of GCs necessitates limiting the side effects of these drugs.

The lipophilic nature of GCs allows them to readily diffuse into the cells, where they bind to a cytosolic receptor, the Glucocorticoid Recetpor (GR) to exert their mechanism of action. Without ligand binding, GR is predominantly localized in cytoplasm, whereas upon ligand binding it rapidly translocates to nucleus where it can both positively and negatively regulate gene expression. GR belongs to the nuclear receptor superfamily of ligand-activated transcription factors that function as powerful metabolic regulators. Several studies have shown that GR also translocates to the mitochondrial in addition to its nuclear translocation in response to GC treatment. The mitochondrial GR translocation has been shown to be positively correlated with GC-induced apoptosis, although the mechanism is unclear.

The mitochondrial-specific GR (Flag and HA tagged)/HEK293 cell line was created by stable transfection of HEK293 cells with a plasmid expressing Flag and HA tagged GR protein with a mitochondrial localization signal.

美國(guó)人糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株

美國(guó)PrimCells品牌介紹

PrimCells是位于美國(guó)加州圣迭戈的一家專業(yè)致力于細(xì)胞產(chǎn)品研發(fā)和解決方案提供的業(yè)內(nèi)技術(shù)。

公司匯集了*的生物醫(yī)藥技術(shù)專家,獨(dú)立開發(fā)了多項(xiàng)原代細(xì)胞和干細(xì)胞相關(guān)的專有技術(shù)。 公司以“細(xì)胞研究的優(yōu)選擇"為宗旨,自主研發(fā)超過70種創(chuàng)新產(chǎn)品,多個(gè)特種細(xì)胞市場(chǎng)的空白。例如其誘導(dǎo)性表達(dá)細(xì)胞庫和高效3D皮膚培養(yǎng)系統(tǒng),皆為該類產(chǎn)品目前市場(chǎng)上少數(shù)的規(guī)?;?yīng)商。此外,公司以高質(zhì)量的數(shù)據(jù)與快速穩(wěn)定的項(xiàng)目完成時(shí)間,長(zhǎng)期為多家制藥公司提供解決方案,獲得用戶廣泛贊譽(yù)。

PrimCells產(chǎn)品線:

  • 報(bào)告基因干細(xì)胞        2. 原代細(xì)胞(含報(bào)告基因原代細(xì)胞)               3. 誘導(dǎo)性穩(wěn)定細(xì)胞株

4. 人源重組蛋白               5.   創(chuàng)新型培養(yǎng)試劑

PrimCells 解決方案

1.誘導(dǎo)性穩(wěn)定細(xì)胞株開發(fā) 2. 原代細(xì)胞開發(fā) 3. 藥物體外毒理和效能測(cè)試 4. 3D-皮膚培養(yǎng)

PrimCells合作伙伴及客戶:

A.生物制藥公司:輝瑞(Pfizer), 諾華(Novartis), 禮來(Eli2  Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和醫(yī)藥研發(fā)部門

B.科研機(jī)構(gòu):冷泉港實(shí)驗(yàn)室,哈佛醫(yī)學(xué)院, 麻省理工(MIT),, UCSF, NYU, Salk, UIUC, USC等

美國(guó)人Glucocorticoid糖皮質(zhì)激素受體穩(wěn)定細(xì)胞株(線粒體表達(dá))















產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號(hào)7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
在线观看国产一区二三区| 熟睡中被进了h青梅诱哄视频| 久久人妻网| 免费簧片| 国产熟女AA级毛片| 欧美18videosex性极品| 8090yy成人免费看片| 欧洲亚洲国产成人综合色婷婷 | 狠狠狠狠狠狠狠综合| 97成人精品一区二区三区| 久久av一区二区三区久久久| 五月婷之久久综合丝袜美腿| 又爽又黄又无遮挡的视频在线观看 | 最新av在线| 中文字幕大香视频蕉免费| 老太性开放bbwbbwbbw| 蜜桃臀无码内射一区二区三区| 国产在线精品| 在线免费观看你懂的| 刺激的乱亲小说43部分阅读 | 伊人久久大香线蕉AV一区| 亚洲一区 日韩精品 中文字幕| 午夜精品一区二区久久做老熟女 | 波多野结衣一区二区三区高清| 熟妇人妻一区二区三区四区| 久久九九| 久久中文字幕人妻丝袜系列 | 久久人午夜亚洲精品无码区| 欧美亚洲国产一区二区三区| 精品免费一区二区在线| 拜泉县| 午夜福利伦伦电影理论片在线观看| 国产伦精品一区二区三区视频金莲| 亚洲理论精品午夜电影| 亚洲国产精品久久久久久久| 久久亚洲精品国产精品| 日韩精品无码久久一区二区三| free性玩弄少妇hd| 色欲香天天天综合网站无码| 麻豆一区二区三区精品视频| 亚洲午夜未满十八勿入网站2|